Effect of omega-3 acids on clinical evolution, plasma inflammatory biomarkers and B-type natriuretic peptide levels in patients with coronary heart disease;Efecto de los ácidos grasos omega-3 en la evolución clínica, biomarcadores inflamatorios y el péptido natriurético cerebral de pacientes con cardiopatía isquémica

Medicina Clinica

Volumn 136, Issue 13, 2011, Pages 574-577

  Martínez Quintana, Efrén ^a   Rodríguez González, Fayna ^a   Torres Fuentes, Estrella ^a   López Ríos, Laura ^b   Nieto Lago, Vicente ^a  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

B type natriuretic peptide; Event; Infarction; Lipids; Omega 3 acids; Ventricular function

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; FIBRINOGEN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ADD ON THERAPY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DISEASE COURSE; DRUG EFFECT; FOLLOW UP; HEART VENTRICLE FUNCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; DRUG ADMINISTRATION SCHEDULE; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; TRIGLYCERIDES;

EID: 79955521996     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.06.009     Document Type: Article

References (10)

1. T.A. Dolecek Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial Proc Soc Exp Biol Med. 200 1992 177 182
2. Gissi-HF Investigators L. Tavazzi, A.P. Maggioni, R. Marchioli, S. Barlera, and M.G. Franzosi Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet. 372 2008 1223 1230
3. M. Yokoyama, H. Origasa, M. Matsuzaki, Y. Matsuzawa, Y. Saito, Y. Ishikawa Japan EPA lipid intervention study (JELIS) Investigators Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis Lancet. 369 2007 1090 1098 (Pubitemid 46483662)
4. GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999; 354:447-55.
5. M. Marqués, D. Parra, M. Kiely, N. Bandarra, I. Thorsdottir, and J.A. Martínez Omega-3 fatty acids inclusion as part of an energy restricted diet to improve the effect on blood lipids Med Clin (Barc). 130 2008 10 12
6. J. Martínez-González, and L. Lina Badimon Estatinas y ácidos grasos omega-3. Disminución de la mortalidad cardiovascular dependiente e independiente de la reducción de la colesterolemia Rev Esp Cardiol. 6 Suppl D 2006 20 30
7. F. Van de Werf, D. Ardissino, A. Betriu, D.V. Cokkinos, E. Falk, and K.A. Fox Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J. 24 2003 28 66
8. Y.T. Zhao, L. Shao, L.L. Teng, B. Hu, Y. Luo, and X. Yu Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure J Int Med Res. 37 2009 1831 1841
9. A. Macchia, G. Levantesi, M.G. Franzosi, E. Geraci, A.P. Maggioni, R. Marfisi GISSI-Prevenzione Investigators Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids Eur J Heart Fail. 7 2005 904 909 (Pubitemid 41125915)
10. M. Matsumoto, T. Tsujino, Y. Naito, M. Lee-Kawabata, A. Ezumi, and K. Yamamoto Anemia as a factor that elevates plasma brain natriuretic peptide concentration in apparently healthy subjects Int Heart J. 49 2008 577 586